Novartis Beats Gleevec Monopolization Suit At 1st Circ.
By RJ Vogt · August 21, 2018, 9:31 PM EDT
The First Circuit on Tuesday granted Novartis' bid to dismiss an antitrust suit alleging it used sham litigation to extend a monopoly over the leukemia drug Gleevec, finding that a group...
To view the full article, register now.
Try a seven day FREE Trial
Already a subscriber? Click here to login